» Articles » PMID: 9397113

Variation in the Incidence of Uterine Leiomyoma Among Premenopausal Women by Age and Race

Overview
Journal Obstet Gynecol
Date 1997 Dec 16
PMID 9397113
Citations 269
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To quantify the incidence of uterine leiomyoma confirmed by hysterectomy, ultrasound, or pelvic examination according to age and race among premenopausal women.

Methods: From September 1989 through May 1993, 95,061 premenopausal nurses age 25-44 with intact uteri and no history of uterine leiomyoma were followed to determine incidence rates of uterine leiomyoma. The self-reported diagnosis was confirmed in 93% of the medical records obtained for a sample of cases. Using pooled logistic regression, we estimated relative risks (RRs) of uterine leiomyoma according to race and examined whether adjustment for other potential risk factors could explain the variation in the race-specific rates.

Results: During 327,065 woman-years, 4181 new cases of uterine leiomyoma were reported. The incidence rates increased with age, and the age-standardized rates of ultrasound- or hysterectomy-confirmed diagnoses per 1000 woman-years were 8.9 among white women and 30.6 among black women. After further adjustment for marital status, body mass index, age at first birth, years since last birth, history of infertility, age at first oral contraceptive use, and current alcohol consumption, the rates among black women were significantly greater for diagnoses confirmed by ultrasound or hysterectomy (RR 3.25; 95% confidence interval [CI] 2.71, 3.88) and by hysterectomy (RR 1.82; 95% CI 1.17, 2.82) compared with rates among white women. We observed similar RRs when the cohort was restricted to participants who reported undergoing a screening physical examination within the 2 years before baseline.

Conclusion: A higher prevalence of known risk factors did not explain the excess rate of uterine leiomyoma among premenopausal black women.

Citing Articles

Uterus transplantation: A clinical breakthrough after systematic preclinical research.

Brannstrom M, Milenkovic M, Tsakos E Reprod Med Biol. 2025; 24(1):e12636.

PMID: 39935690 PMC: 11811759. DOI: 10.1002/rmb2.12636.


Lower Urinary Tract Symptoms in Relation to Leiomyoma Volume, Location, and Position in Reproductive-aged Women in the USA.

Huang A, Schembri M, Raghunathan H, Kho K, Williams N, Sobolewski C Int Urogynecol J. 2025; 36(2):447-455.

PMID: 39833537 DOI: 10.1007/s00192-024-06027-4.


Epidemiological features of uterine fibroid-associated imaging changes in Chinese women of reproductive age: a retrospective study.

Zhang L, Xu F, Huang Y, Xu W, Pu Y, Chen K BMJ Open. 2025; 15(1):e085671.

PMID: 39773792 PMC: 11749307. DOI: 10.1136/bmjopen-2024-085671.


Endometriosis and uterine fibroids and risk of premature mortality: prospective cohort study.

Wang Y, Farland L, Gaskins A, Wang S, Terry K, Rexrode K BMJ. 2024; 387:e078797.

PMID: 39567014 PMC: 11577545. DOI: 10.1136/bmj-2023-078797.


The Annual Economic Burden of Uterine Fibroids in the United States (2010 Versus 2022): A Comparative Cost-Analysis.

Hazimeh D, Coco A, Casubhoy I, Segars J, Singh B Reprod Sci. 2024; 31(12):3743-3756.

PMID: 39455488 DOI: 10.1007/s43032-024-01727-0.